Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical screen not yet scored
Price1,214.00 GBp
Ethical score70.0/100
Our investment reviews on this name
2026-10-02Read Markdown1,214.00+0.0% to today
2026-09-02Read Accumulation1,200.00+1.2% to today ✓
2026-08-03Read Markdown1,200.00+1.2% to today
2026-07-02Read Accumulation1,200.00+1.2% to today ✓
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
JPMorgan American Ord holds its Markdown at $1,214.00. The statistical read favours the buyers, held for 262 days.
As held on the ledger · 2026-09-18
Phase
Markdown · caution
Quantitative state
The statistical read favours the buyers, held for 262 days
Price at the screen
$1,214.00
Valuation
26.09 trailing · N/A forward price to earnings
Values screen
Not scored· score 70.0
The Workings
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
5.05%
Below 33%
Interest-bearing debt is just 5.1% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.54%
Below 33%
Cash held in interest-bearing accounts and securities is 0.5% of assets, under the one-third limit.
Pass
Receivables
0.23%
Below 49%
Money owed to the company is 0.2% of assets, under the 49% limit.
Pass
Revenue purity
0.97%
Below 5%
Only 1.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
The Read, in Plain English
We do not yet have the financial statements needed to run the debt, cash, receivables and income screens for JPMorgan American Ord, so it is not scored yet.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is Worth
The Fair Value Range
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-18 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
JAM.L trades on LSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-02Markdown · changed$1,214.00+1.2%Entry 6
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (1 analysts) rates it none, with a mean price target of $115800.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (1 analysts) rates it none, with a mean price target of $115800.
2026-08-03Markdown · changed$1,200.00+0.0%Entry 4
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (1 analysts) rates it none, with a mean price target of $115800.
2026-07-18Accumulation$1,200.00+0.0%Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (1 analysts) rates it none, with a mean price target of $115800.
2026-07-03Accumulation$1,200.00+0.0%Entry 2
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Accumulation$1,200.00Entry 1
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
Period
Price then
Price return
Divs per share
$1,000 became
Total return
1 month
$1,180.00
+0.2%
·
$1,002
+0.2%
2 months
$1,117.91
+5.7%
$8.75
$1,065
+6.5%
3 months
$1,111.91
+6.3%
$8.75
$1,071
+7.1%
6 months
$1,123.91
+5.2%
$8.75
$1,059
+5.9%
1 year
$1,005.90
+17.5%
$11.50
$1,187
+18.7%
2 years
$942.79
+25.4%
$22.50
$1,278
+27.8%
3 years
$747.77
+58.1%
$30.25
$1,621
+62.1%
5 years
$639.68
+84.8%
$44.50
$1,917
+91.7%
Historical returns from market close data. Past performance does not guarantee future results.
The Ledger's Promise
This entry now belongs to the ledger. Whatever JAM.L does next, these words stay.
JPMorgan American Ord · JAM.L · Markdown · $1,214.00
Recorded 2026-09-18 · before the outcome · scored mechanically